An Association between Bevacizumab and Recurrent Posterior Reversible Encephalopathy Syndrome in a Patient Presenting with Deep Vein Thrombosis: A Case Report and Review of the Literature.

Atypical reversible leucoencephalopathy syndrome after bevacizumab/folfox regimen for metastatic colon cancer. Case Rep Oncol Med (2014) 0.80

Reversible posterior encephalopathy syndrome secondary to sunitinib. Case Rep Oncol Med (2014) 0.79

Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer. Invest New Drugs (2014) 0.78

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med (2006) 34.52

A reversible posterior leukoencephalopathy syndrome. N Engl J Med (1996) 23.35

Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA (2008) 7.13

Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21

Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc (2010) 5.42

VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med (2006) 2.67

Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med (2006) 2.28

Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology (2000) 1.88

Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am J Physiol Cell Physiol (2001) 1.74

Circulating biomarkers of bevacizumab activity in patients with breast cancer. Cancer Biol Ther (2007) 1.68

Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med (2006) 1.58

Bevacizumab, bleeding, thrombosis, and warfarin. J Clin Oncol (2003) 1.41

"Recurrent" posterior reversible encephalopathy syndrome: report of 3 cases--PRES can strike twice! J Comput Assist Tomogr (2007) 1.35

Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol (2006) 1.29

Recurrent posterior reversible encephalopathy syndrome (PRES). J Hum Hypertens (2004) 1.24

Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia. J Korean Med Sci (2004) 0.95

Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia. J Pregnancy (2011) 0.91

Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol (2000) 0.89

Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia. Eur J Obstet Gynecol Reprod Biol (2007) 0.89

Posterior reversible encephalopathy syndrome with bevacizumab. Hong Kong Med J (2011) 0.85

Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality. Nat Struct Mol Biol (2009) 1.13

Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res (2008) 1.04

Evidence for annexin II-S100A10 complex and plasmin in mobilization of cytokine activity of human TrpRS. J Biol Chem (2007) 0.99

Evaluation and management of the acutely dyspneic patient: the role of biomarkers. Am J Emerg Med (2005) 0.86